[ Price : $8.95]
FDA clears a MedRhythms 510(k) for InTandem, a neurorehabilitation system to improve walking and ambulation in stroke patients.[ Price : $8.95]
FDA clears an EarliTec Diagnostics 510(k) for the second generation of its EarliPoint Evaluation for Autism Spectrum Disorder in c...[ Price : $8.95]
Senators Mike Lee (R-UT), Ben Ray Lujn (D-NM), Mike Braun (R-IN), and J.D. Vance (R-OH) introduce a bill to ease biosimilar interc...[ Price : $8.95]
Federal Register notice: FDA makes available a draft guidance entitled Manufacturing Changes and Comparability for Human Cellular ...[ Price : $8.95]
Federal Register notice: FDA makes available a draft guidance entitled Postmarketing Studies and Clinical Trials: Determining Good...[ Price : $8.95]
FDA approves a Gilead Sciences supplemental NDA for the use of Veklury (remdesivir) in Covid-19 patients with severe renal impairm...[ Price : $8.95]
FDA publishes a draft guidance on managing manufacturing changes for human cellular and gene therapy products.[ Price : $8.95]
FDA approves a Laboratoire HRA Pharma (recently acquired by Perrigo) NDA to move its contraceptive Opill (norgestrel) tablet from ...